Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on November 4-5, 2024. A sample of agenda items to be discussed during the public session includes: an overview of the Advance Act; an update on the Medical Radiation Safety Team's activities; ACMUI bylaws update; status of patient release guidance revision; NRC review of recent yttrium-90 microsphere medical events; and NRC evaluation of current patient waste regulations and guidance. The agenda is subject to change. The current agenda and any updates will be available on the ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/ reading-rm/doc-collections/acmui/meetings/2024.html or by emailing Ms. L. Armstead and T. Roszkowski at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: November 4, 2024, from 10:00 a.m. to 4:35 p.m. EST. Date and Time for Closed Session: November 5, 2024, from 9:30 a.m. to 11:30 a.m. EST. This session will be closed to conduct the ACMUI's required annual training. Address for Public Meeting: This is a virtual meeting
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 195 (Tuesday, October 8, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 195 (Tuesday, October 8, 2024)]
[Notices]
[Page 81579]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-23168]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on November 4-5, 2024. A sample of agenda items to be discussed
during the public session includes: an overview of the Advance Act; an
update on the Medical Radiation Safety Team's activities; ACMUI bylaws
update; status of patient release guidance revision; NRC review of
recent yttrium-90 microsphere medical events; and NRC evaluation of
current patient waste regulations and guidance. The agenda is subject
to change. The current agenda and any updates will be available on the
ACMUI's Meetings and Related Documents web page at <a href="https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html">https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html</a> or by emailing Ms.
L. Armstead and T. Roszkowski at the contact information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: November 4, 2024, from 10:00 a.m.
to 4:35 p.m. EST.
Date and Time for Closed Session: November 5, 2024, from 9:30 a.m.
to 11:30 a.m. EST. This session will be closed to conduct the ACMUI's
required annual training.
Address for Public Meeting: This is a virtual meeting
------------------------------------------------------------------------
Webinar information (Microsoft
Date Teams)
------------------------------------------------------------------------
November 4-5, 2024..................... Link: <a href="https://teams.microsoft.com/l/meetup-join/19%3ameeting_M2Q3MzczZWUtNGUxZS00ZWNlLThmNmUtNjM4Y2ZhYTYxYTA0%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d">https://teams.microsoft.com/l/meetup-join/19%3ameeting_M2Q3MzczZWUtNGUxZS00ZWNlLThmNmUtNjM4Y2ZhYTYxYTA0%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d</a>.
Meeting ID: 294 578 901 723.
Passcode: UaHF5t.
Call in number (audio only): +1
301-576-2978, Silver Spring,
MD.
Phone Conference ID: 277 173
020#.
------------------------------------------------------------------------
Public Participation: Any member of the public who wishes to
participate in the teleconference should contact Ms. Armstead and Ms.
Roszkowski using the contact information below.
Contact Information: Ms. L. Armstead, email: <a href="/cdn-cgi/l/email-protection#04687c6531446a76672a636b72"><span class="__cf_email__" data-cfemail="e68a9e87d3a6889485c8818990">[email protected]</span></a> and Ms.
T. Roszkowski, email: <a href="/cdn-cgi/l/email-protection#a4d2cad6e4cad6c78ac3cbd2"><span class="__cf_email__" data-cfemail="483e263a08263a2b662f273e">[email protected]</span></a>.
Conduct of the Meeting
The ACMUI Chair, Dr. Hossein Jadvar, will preside over the meeting.
Dr. Jadvar will conduct the meeting in a manner that will facilitate
the orderly conduct of business. The following procedures apply to
public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. L. Armstead and Ms. T. Roszkowski using the
contact information listed above. All submittals must be received by
the close of business on October 29, 2024, and must only pertain to the
topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website <a href="https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html">https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html</a> on or about December 17, 2024.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. L. Armstead and Ms. T. Roszkowski
of their planned participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations, part 7.
Dated at Rockville, Maryland this this 2nd day of October, 2024.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-23168 Filed 10-7-24; 8:45 am]
BILLING CODE 7590-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.